VITREAL S - Fidia Farmaceutici S.p.A.

VITREAL S

TRIAMCINOLONE ACETONIDE STERILE OPHTHALMIC SUSPENSION

DESCRIPTION

VITREAL S is a sterile ophthalmic suspension containing 4.0 % Triamcinolone Acetonide.
The deposit of Triamcinolone Acetonide microparticles in the vitreous body determines its opacification, facilitating its removal.

INDICATION

VITREAL S is indicated for the staining of the vitreous body during vitrectomy.

COMPOSITION

Triamcinolone Acetonide 4,0%

AVAILABLE
FORMULATION

1 vial containing 2 ml ophthalmic suspension.

DOSING,
ADMINISTRATION
AND INSTRUCTION
FOR USE

Intravitreal use during a vitrectomy surgery.
VITREAL S should be administered by an ophthalmologist specialised in intravitreal injections under aseptic conditions.

PRECAUTIONS AND WARNINGS

  • The product is for intravitreal use only during a vitrectomy surgery. Do not use intravenously or intramuscularly, and do not use as an anti-inflammatory therapy.
  • The product is single use. The volume contained in the bottle can be used for a single patient during a single surgical procedure at the end of which, the residual content of the bottle must be discarded. Reuse  of residual content may result in an ophthalmic infection and/or damage to the patient.
  • Before using VITREAL S during the vitrectomy surgery, check for the presence of any interaction between triamcinolone acetonide and other drugs administered to the patient.
  • Do not use the product if the bottle is damaged.
  • Do not use the product if agglomerates are present in the bottle after vigorous shaking.
  • The patient should be informed that, after the surgery and until visual acuity returns to normal, it is forbidden to drive vehicles or carry out an activity on dangerous machines.
  • Keep the product out of the sight and reach of children.

REFERENCES
Vitreal S Package Insert.